3 results match your criteria: "Miyagi Cancer Center Institute.[Affiliation]"

To determine the relation between serum selenium (Se) values and the development of cancer, we compared serum Se levels among cancer patients, non-cancer patients, and healthy adults. Serum Se values in cancer patients were examined with respect to primary cancer sites separately. We tracked non-cancer patients and healthy people for 5 years after serum collection to examine whether low Se status is a risk factor for cancer.

View Article and Find Full Text PDF

[Serum selenium contents and the risk of cancer].

Gan To Kagaku Ryoho

October 1998

Division of Cancer Pharmacotherapy, Miyagi Cancer Center Institute.

To investigate the relationship between serum Se contents and the risk of cancer, 4857 serum samples were obtained from cancerous (2730) and non-cancerous patients (2127). In this cohort, the incidence of cancer in the non-cancerous patients was followed for the subsequent 3 years. The serum Se level of non-cancerous patients who later developed cancer during the 3 years was determined and compared with that of the non-cancerous patients.

View Article and Find Full Text PDF

[Serum selenium contents in cancer patients].

Gan To Kagaku Ryoho

February 1997

Division of Cancer Pharmacotherapy, Miyagi Cancer Center Institute.

The conclusions were confirmed by determining the serum Selenium levels in 2099 cancerous of non-cancerous patients as follows: 1) The mean serum Selenium levels of males is significantly higher than in females. 2) Serum Selenium levels tend to decrease with age. 3) The serum Selenium levels of cancerous patients is significantly lower than in non-cancerous patients.

View Article and Find Full Text PDF